Please login to the form below

Reed Smith

This page shows the latest Reed Smith news and features for those working in and with pharma, biotech and healthcare.

Another front, it seems, is opening up. The Author. Edward Miller is partner at Reed Smith.

EU report accuses industry of anti-competitive practices

Commenting on the report, Edward Miller, partner in the competition team at law firm Reed Smith, said: "The truth is that there is really nothing new in any of these allegations
ECJ rules against GSK in parallel trade case

Edward Miller, partner in competition team at international law firm Reed Smith.
News in brief, May 02, 2007

Dr Kumar spent a large part of his career at SmithKline Beecham and GSK where he held key executive positions of vice-president and director of Neuroscience and GI, Smith Kline ... Bloch joins King &Spalding from Reed Smith LLP, where he was a partner.

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Managing misconduct allegations

is a partner at Reed Smith. 1st February 2018.
M&A is now vital to pharma - but it's vital to get it right

Research suggests the same - a global study of senior executives at life sciences companies conducted at the end of last year by law firm Reed Smith found 94% were planning an

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Commercial Finance Director, Healthcare Marketing Communications...: up to £90K

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Add my company

Windrose Consulting Group helps life science companies maximize the commercial value of their products and bring new innovations to market...

Mistrust in medical research: a patient perspective: The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease: Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients: We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...